Neopharm's Atonyl to enter the Southeast Asian market.

Neopharm Inc. (www.neopharm.co.kr) said that Atonil, an anti-atopic dermatitis drug, would be exported to Taiwan from Oct. this year under the distribution agreement with Youngshin Pharm. co., an affiliate company of YSP group, one of the largest Taiwanese pharmaceutical business groups.

The first order will be amounted to U$250 thousand, and the market will be extended to the South East Asi...